March 23 (Reuters) - Bard1 Life Sciences Ltd BD1.AX :
* Announced successful completion of a clinical trial using its proprietary ovarian cancer diagnostic test Source text for Eikon: Further company coverage: BD1.AX
March 23 (Reuters) - Bard1 Life Sciences Ltd BD1.AX :
* Announced successful completion of a clinical trial using its proprietary ovarian cancer diagnostic test Source text for Eikon: Further company coverage: BD1.AX